Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
Drugmakers are racing to catch up to Madrigal Pharmaceuticals, which has the first drug for NASH liver disease. Meanwhile, AI
Read MoreDrugmakers are racing to catch up to Madrigal Pharmaceuticals, which has the first drug for NASH liver disease. Meanwhile, AI
Read MoreThese are the stocks posting the largest moves in midday trading. Source link
Read MoreThese are the stocks posting the largest moves in early trading. Source link
Read MoreIn Tony Zhang's opinion, the upside in GE is limited and an opportunity to fade this incredible strength and momentum.
Read MoreThe rollout of Alzheimer's treatment Leqembi from Biogen is going slower than expected, providing a read-through for Club stock Eli
Read MoreQuestions remain for investors after some major disappointments in an intense week suggest more challenges ahead. Source link
Read MoreHere are the biggest calls on Wall Street on Source link
Read MoreHere are the biggest calls on Wall Street on Source link
Read MoreDespite the negative impact from Covid-19, "we still see very strong and growing awareness and motivations for Chinese enterprises, who
Read More